NCR1 and hepatocellular carcinoma: Anti- NKp46 blockaded NK cells displayed a significantly lower specific cytolytic activity against the hepatoma cell lines (HepG2, p = 0.02; HepG2.215, p = 0.039; Fig 4B, S5 Table)